(Q33895456)

29 July 2017

1 reference

title

Placebo effect in randomized, controlled studies of acute bipolar mania and depression (English)

1 reference

29 July 2017

0 references

1 reference

3

McElroy SL

1 reference

29 July 2017

1

Keck PE Jr

1 reference

29 July 2017

Welge JA

2

1 reference

29 July 2017

Arnold LM

series ordinal

4

1 reference

29 July 2017

Strakowski SM

series ordinal

5

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

29 July 2017

Biological Psychiatry

1 reference

29 July 2017

47

1 reference

29 July 2017

748-755

1 reference

29 July 2017

8

1 reference

Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Effect size of efficacy measures comparing divalproex, lithium and placebo in acute mania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

A Controlled Trial of L-Tryptophan in Mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

A controlled clinical trial of L-tryptophan in acute mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Lecithin in the treatment of mania: double-blind, placebo-controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Use of calcium antagonists in mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Calcium antagonists in mania: a double-blind study of verapamil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Action of Propranolol in Mania: Comparison of Effects of the d- and the l-stereoisomer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Antimanic effects of verapamil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Lithium Response in Unipolar Versus Bipolar Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

A double-blind study of tranylcypromine treatment of major anergic depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Verapamil for the treatment of acute mania: a double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Importance of Psychiatric Diagnosis in Prediction of Clinical Drug Effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Treatment of mania with the cholinomimetic agent RS 86

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Double-blind, controlled trial of inositol treatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Use of placebos in clinical trials involving children and adolescents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Lithium treatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Valproate in the treatment of acute mania. A placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Placebos, drug effects, and study design: a clinician's guide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

The treatment of manic psychoses by the administration of lithium salts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Letter: How blind is the double-blind?: an assessment in a lithium-prophylaxis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

Efficacy of lithium as acute treatment of manic-depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

7 January 2021

RS 86 in manic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900311-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(99)00311-X

1 reference

29 July 2017

1 reference